摘要
肠道菌群与2型糖尿病的发生发展关系密切,部分降糖药物通过肠道菌群发挥作用。降糖药物通过肠道菌群、肠道激素分泌、胆汁酸代谢、短链脂肪酸、炎性反应等网络化机制来影响2型糖尿病的发生发展。
Gut microbiota is closely related to the occurrence and development of type 2 diabetes,and some hypoglycemic drugs work through the gut microbiota.Hypoglycemic drugs affect the occurrence and development of type 2 diabetes through networked mechanisms such as gut microbiota,intestinal hormone secretion,bile acid metabolism,short-chain fatty acid,inflammatory response and so on.
作者
吕晶(综述)
杨杨(审校)
LV Jing;YANG Yang(Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan 430000,China)
出处
《微循环学杂志》
2020年第1期73-77,共5页
Chinese Journal of Microcirculation
关键词
肠道菌群
2型糖尿病
降糖药物
Gut microbiota
Type 2 diabetes
Hypoglycemic drugs
